Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Opioid Use, Lumbar Spinal Stenosis, Pain, Postoperative, Pain, Back
In brief
This study seeks to evaluate the impact of intra-operative topical epidural steroid usage in patients undergoing 1-2 level lumbar laminectomy. The study will examine post-operative opioid usage, length of stay, return to work, and patient reported outcomes following these procedures.
Key facts
- Study ID
- NCT05058287
- Run by
- Hospital for Special Surgery, New York
- People needed
- 150
- Starts
- 2021-11-05
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-04-28
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients scheduled to undergo 1 to 2 level laminectomy
- Between the ages of 18-85
You may not qualify if…
- Minimally invasive surgery
- Prior daily opioid usage within 6 months.
- Use of concomitant procedures such as spinal fusion, revision procedure at the same level.
- History of a chronic pain syndrome, uncontrolled diabetes defined as A1C > 6.5, immunocompromised condition such as active cancer treatment, history of transplant, benign prostatic hyperplasia or history of urinary retention, and other conditions which require chronic steroid therapy or immunosuppressants.
- Non-English speakers
- Patients allergic to Depo-Medrol and/or glucocorticoids, or other steroids
Where it is running
- Hospital for Special Surgery — New York, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.